Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Romiplostim for poor platelet engraftment after HSCT in hematologic diseases
ChiCTR2600118990Phase 4Not yet recruiting
- Sponsor
- Huai'an Second Hospital
- Start
- Feb 2026
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of romiplostim in Delayed platelet engraftment (DPE), sponsored by Huai'an Second Hospital. Primary endpoint: Platelet engraftment time. Planned start Feb 2026; status: not yet recruiting.
02
Drugs
romiplostim
03
Conditions
Delayed platelet engraftment (DPE)
Beyond the preview
Go deeper on ChiCTR2600118990.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2600118990.